Royal Bank of Canada’s Cidara Therapeutics CDTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
+31,267
| New | +$1.52M | ﹤0.01% | 3238 |
|
|
2024
Q3 | – | Sell |
-67
| Closed | -$1K | – | 6420 |
|
|
2024
Q2 | $1K | Buy |
+67
| New | +$1K | ﹤0.01% | 6398 |
|
|
2024
Q1 | – | Sell |
-246
| Closed | – | – | 6565 |
|
|
2023
Q4 | $0 | Sell |
246
-6,206
| -96% | – | ﹤0.01% | 6597 |
|
|
2023
Q3 | $6K | Buy |
6,452
+3,210
| +99% | +$2.99K | ﹤0.01% | 6063 |
|
|
2023
Q2 | $4K | Sell |
3,242
-18,517
| -85% | -$22.8K | ﹤0.01% | 6260 |
|
|
2023
Q1 | $27K | Buy |
21,759
+21,744
| +144,960% | +$27K | ﹤0.01% | 5520 |
|
|
2022
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 6770 |
|
|
2021
Q3 | – | Sell |
-1,980
| Closed | -$4K | – | 7098 |
|
|
2021
Q2 | $4K | Sell |
1,980
-1,866
| -49% | -$3.77K | ﹤0.01% | 6602 |
|
|
2021
Q1 | $10K | Buy |
3,846
+938
| +32% | +$2.44K | ﹤0.01% | 6298 |
|
|
2020
Q4 | $6K | Buy |
2,908
+2,905
| +96,833% | +$5.99K | ﹤0.01% | 6020 |
|
|
2020
Q3 | $0 | Sell |
3
-611
| -100% | – | ﹤0.01% | 6127 |
|
|
2020
Q2 | $2K | Buy |
+614
| New | +$2K | ﹤0.01% | 5791 |
|
|
2019
Q4 | – | Sell |
-474
| Closed | -$1K | – | 6203 |
|
|
2019
Q3 | $1K | Buy |
+474
| New | +$1K | ﹤0.01% | 5735 |
|
|
2018
Q4 | – | Sell |
-43
| Closed | – | – | 5825 |
|
|
2018
Q3 | $0 | Buy |
+43
| New | – | ﹤0.01% | 6103 |
|
|
2017
Q2 | – | Sell |
-504
| Closed | -$4K | – | 5800 |
|
|
2017
Q1 | $4K | Sell |
504
-254
| -34% | -$2.02K | ﹤0.01% | 5581 |
|
|
2016
Q4 | $8K | Buy |
+758
| New | +$8K | ﹤0.01% | 5385 |
|
|
2015
Q4 | – | Sell |
-294
| Closed | -$4K | – | 5854 |
|
|
2015
Q3 | $4K | Sell |
294
-35
| -11% | -$476 | ﹤0.01% | 5614 |
|
|
2015
Q2 | $5K | Buy |
+329
| New | +$5K | ﹤0.01% | 5734 |
|